Goldman Sachs’s PDS Biotechnology PDSB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-317,460
| Closed | -$930K | – | 4960 |
|
|
2024
Q2 | $930K | Buy |
317,460
+226,986
| +251% | +$665K | ﹤0.01% | 3612 |
|
|
2024
Q1 | $358K | Buy |
90,474
+77,988
| +625% | +$309K | ﹤0.01% | 4121 |
|
|
2023
Q4 | $62.1K | Sell |
12,486
-836
| -6% | -$4.16K | ﹤0.01% | 4522 |
|
|
2023
Q3 | $67.3K | Sell |
13,322
-14,376
| -52% | -$72.6K | ﹤0.01% | 4449 |
|
|
2023
Q2 | $139K | Sell |
27,698
-57,473
| -67% | -$289K | ﹤0.01% | 4501 |
|
|
2023
Q1 | $524K | Buy |
+85,171
| New | +$524K | ﹤0.01% | 4044 |
|
|
2022
Q2 | – | Sell |
-29,752
| Closed | -$184K | – | 5811 |
|
|
2022
Q1 | $184K | Sell |
29,752
-2,010
| -6% | -$12.4K | ﹤0.01% | 5128 |
|
|
2021
Q4 | $257K | Buy |
31,762
+20,367
| +179% | +$165K | ﹤0.01% | 4854 |
|
|
2021
Q3 | $170K | Buy |
+11,395
| New | +$170K | ﹤0.01% | 4918 |
|
|
2021
Q2 | – | Sell |
-20,867
| Closed | -$95K | – | 5501 |
|
|
2021
Q1 | $95K | Buy |
20,867
+1,267
| +6% | +$5.77K | ﹤0.01% | 5051 |
|
|
2020
Q4 | $42K | Buy |
+19,600
| New | +$42K | ﹤0.01% | 4574 |
|
|
2018
Q4 | – | Sell |
-106,875
| Closed | -$88K | – | 4205 |
|
|
2018
Q3 | $88K | Sell |
106,875
-37,302
| -26% | -$30.7K | ﹤0.01% | 3975 |
|
|
2018
Q2 | $149K | Buy |
144,177
+123,952
| +613% | +$128K | ﹤0.01% | 3942 |
|
|
2018
Q1 | $24K | Buy |
+20,225
| New | +$24K | ﹤0.01% | 4134 |
|
|
2017
Q3 | – | Sell |
-36,487
| Closed | -$374K | – | 4363 |
|
|
2017
Q2 | $374K | Buy |
+36,487
| New | +$374K | ﹤0.01% | 3681 |
|
|
2017
Q1 | – | Sell |
-28,897
| Closed | -$361K | – | 4502 |
|
|
2016
Q4 | $361K | Buy |
+28,897
| New | +$361K | ﹤0.01% | 3624 |
|
|
2016
Q3 | – | Sell |
-44,786
| Closed | -$453K | – | 4611 |
|
|
2016
Q2 | $453K | Buy |
+44,786
| New | +$453K | ﹤0.01% | 3373 |
|